NASDAQ: OMCL - Omnicell, Inc.

Yield per half year: +47.52%
Sector: Healthcare

Omnicell, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
393.58 48.72 707.8% 119.22 +230.14%
P/S 1.55 33.75 -95.42%
P/BV 1.49 4.82 -69.04%
P/FCF 20.94 61 -65.67%
Ev/Ebitda -54.1 -22.17 144%
Ev/S 1.64 22.56 -92.71%
Ev/FCF 14.96 68.75 -78.24%
E/P -0.0077 0.0178 -143.32%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-3.04 4.98 -161.07% 9.55 -131.84%
ROE -1.71 9.61 -117.83%
ROA -0.9148 0.3443 -365.72%
ROIC 4.46 7.63 -41.58%
ROS -1.78 -25.17 -92.93%
ROCE -2.93 15.35 -119.1%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-16.64 -3.68 352.68% -8.3 +100.5%
Nеt Debt/Ebitda -3.24 -3.44 -5.61%
Debt/Ratio 0.2605 0.1985 31.26%
Debt/Equity 6.17 1.66 271.31%
Debt/Net Income -28.48 10.32 -375.88%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5473 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 1.07 -100%
Average percentage for 5 years 0 0.498 -100%
Average percentage for payments 140.51 43.56 222.54%
Difference from average difference in sector -0.5473

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
27.88 -56.89 -149.01%
Growth impulse Ebitda in 5 years -124.47 -54.68 127.63%
Growth impulse Net Income in 5 years -133.23 -58.33 128.41%
Growth impulse FCF in 5 years 51.35 -49.48 -203.78%
Growth impulse EPS in 5 years -131.51 -32.41 305.77%
IP Score
3.33/10

Similar companies

DENTSPLY SIRONA

Alexion

Amgen

ABIOMED

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription